retatrutide clinical trial doses dosing frequency Retatrutide Dosage Chart: Everything You Need to Know retatrutide clinical trial dosing frequency

Phase 2 data published in the New England Journal of Medicine demonstrated substantial weight reduction in some participants exceeding 20% of body weight over 48 weeks alongside improvements in cardiometabolic markers

Triggers include increased consumption of acidic foods, caffeine, or large meals, though most people experience improvement once they lose weight and identify personal trigger foods

JAMA 324 , 879 (2020)

The following safety considerations are critical for any research application

Whether tirzepatide or retatrutide proves to be the optimal choice for a given individual will depend on factors that continue to clarify as clinical evidence accumulates

Dehydration plus reduced GI motility equals severe constipation